FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

430306004: Certolizumab pegol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2708529014 Certolizumab pegol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2764885014 Certolizumab pegol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2708529014 Certolizumab pegol (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2708529014 Certolizumab pegol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2764885014 Certolizumab pegol en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2764885014 Certolizumab pegol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
372131000195115 certolizumab pegolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
654431000274114 Certolizumab Pegol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
367461000077114 certolizumab pegol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799481000172116 certolizumab pégol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
367461000077114 certolizumab pegol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799481000172116 certolizumab pégol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
372131000195115 certolizumab pegolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
654431000274114 Certolizumab Pegol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3340611001000118 Certolizumab pegol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Certolizumab pegol Is a agent contre une maladie inflammatoire de l'intestin false Inferred relationship Existential restriction modifier (core metadata concept)
Certolizumab pegol Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Certolizumab pegol Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Certolizumab pegol Is a Gastrointestinal agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Certolizumab pegol Has disposition Tumor necrosis factor alpha inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Certolizumab pegol Is a Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Certolizumab pegol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1
Certolizumab pegol 200mg powder for injection solution vial + diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept)
Certolizumab pegol therapy (procedure) Direct substance True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only certolizumab pegol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing certolizumab pegol in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1
Certolizumab pegol only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1
Certolizumab pegol 200 mg/mL solution for injection Has precise active ingredient True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1
Certolizumab pegol 200 mg/mL solution for injection Has basis of strength substance (attribute) True Certolizumab pegol Inferred relationship Existential restriction modifier (core metadata concept) 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start